{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:44:15Z","timestamp":1740159855543,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s13318-021-00749-2","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T15:02:32Z","timestamp":1642172552000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors Associated with Suboptimal Tobramycin Levels in the Medical Intensive Care Unit"],"prefix":"10.1007","volume":"47","author":[{"given":"Jacob P.","family":"Counts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-471X","authenticated-orcid":false,"given":"Jessica L.","family":"Elefritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica E.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilly","family":"Palettas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor","family":"Aossey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia J.","family":"Beatty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"issue":"6","key":"749_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/sur.2007.080","volume":"10","author":"EW Mueller","year":"2009","unstructured":"Mueller EW, Boucher BA. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Surg Infect (Larchmt). 2009;10(6):563\u201370. https:\/\/doi.org\/10.1089\/sur.2007.080.","journal-title":"Surg Infect (Larchmt)"},{"issue":"3","key":"749_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","volume":"37","author":"JA Roberts","year":"2009","unstructured":"Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med. 2009;37(3):840\u201359. https:\/\/doi.org\/10.1097\/CCM.0b013e3181961bff.","journal-title":"Crit Care Med"},{"issue":"2","key":"749_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40262-016-0428-x","volume":"56","author":"A Marsot","year":"2017","unstructured":"Marsot A, Guilhaumou R, Riff C, Blin O. Amikacin in critically Ill patients: a review of population pharmacokinetic studies. Clin Pharmacokinet. 2017;56(2):127\u201338. https:\/\/doi.org\/10.1007\/s40262-016-0428-x.","journal-title":"Clin Pharmacokinet"},{"issue":"16","key":"749_CR4","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2146\/ajhp140564","volume":"72","author":"MS Stankowicz","year":"2015","unstructured":"Stankowicz MS, Ibrahim J, Brown DL. Once-daily aminoglycoside dosing: an update on current literature. Am J Health Syst Pharm. 2015;72(16):1357\u201364. https:\/\/doi.org\/10.2146\/ajhp140564.","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"749_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2165\/00003088-200544100-00002","volume":"44","author":"F Pea","year":"2005","unstructured":"Pea F, Viale P, Furlanut M. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin Pharmacokinet. 2005;44(10):1009\u201334. https:\/\/doi.org\/10.2165\/00003088-200544100-00002.","journal-title":"Clin Pharmacokinet"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00003246-198804000-00004","volume":"16","author":"JF Dasta","year":"1988","unstructured":"Dasta JF, Amstrong DK. Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. Crit Care Med. 1988;16:327\u201330. https:\/\/doi.org\/10.1097\/00003246-198804000-00004.","journal-title":"Crit Care Med"},{"issue":"5","key":"749_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00005373-200011000-00013","volume":"49","author":"JF Barletta","year":"2000","unstructured":"Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. J Trauma. 2000;49(5):869\u201372. https:\/\/doi.org\/10.1097\/00005373-200011000-00013.","journal-title":"J Trauma"},{"issue":"1","key":"749_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210012","volume":"14","author":"M Cobussen","year":"2019","unstructured":"Cobussen M, Stassen PM, Posthouwer D, et al. Improving peak concentrations of a single dose regime of gentamicin in patients with sepsis in the emergency department. PLoS ONE. 2019;14(1): e0210012. https:\/\/doi.org\/10.1371\/journal.pone.0210012 (Published 2019 Jan 22).","journal-title":"PLoS ONE"},{"issue":"10","key":"749_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1089\/sur.2020.012","volume":"21","author":"TM Grucz","year":"2020","unstructured":"Grucz TM, Kruer RM, Bernice F, et al. Aminoglycoside dosing and volume of distribution in critically ill surgery patients. Surg Infect (Larchmt). 2020;21(10):859\u201364. https:\/\/doi.org\/10.1089\/sur.2020.012.","journal-title":"Surg Infect (Larchmt)"},{"issue":"2","key":"749_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijantimicag.2016.10.022","volume":"49","author":"CJ Hodiamont","year":"2017","unstructured":"Hodiamont CJ, Juffermans NP, Bouman CS, de Jong MD, Math\u00f4t RA, van Hest RM. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis. Int J Antimicrob Agents. 2017;49(2):204\u201311. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.10.022.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"749_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/01.ccm.0000649352.40820.95","volume":"48","author":"J Beatty","year":"2020","unstructured":"Beatty J, Ernst N, Droege C, Droege M, Philpott C, Mueller E. 1764: Aminoglycoside pharmacokinetic comparison between critically ill trauma and non-trauma patients. Crit Care Med. 2020;48(1):856.","journal-title":"Crit Care Med"},{"issue":"6","key":"749_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/FTD.0b013e31818b6b2f","volume":"30","author":"RS Rea","year":"2008","unstructured":"Rea RS, Capitano B, Bies R, Bigos KL, Smith R, Lee H. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit. 2008;30(6):674\u201381. https:\/\/doi.org\/10.1097\/FTD.0b013e31818b6b2f.","journal-title":"Ther Drug Monit"},{"key":"749_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ckj\/sfs160","volume":"6","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Jorge S. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J. 2013;6:8\u201314. https:\/\/doi.org\/10.1093\/ckj\/sfs160.","journal-title":"Clin Kidney J"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","volume":"155","author":"RD Moore","year":"1987","unstructured":"Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987;155:93\u20139. https:\/\/doi.org\/10.1093\/infdis\/155.1.93.","journal-title":"J Infect Dis"},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1128\/AAC.43.3.623","volume":"43","author":"AD Kashuba","year":"1999","unstructured":"Kashuba AD, Nafziger AN, Drusano GL, et al. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrob Agents Chemother. 1999;43:623\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"749_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"key":"749_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. REDCap Consortium, The REDCap consortium: building an international community of software partners. J Biomed Inform. 2019. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"749_CR18","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580\u2013637.","journal-title":"Crit Care Med"},{"issue":"5","key":"749_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00007691-199410000-00013","volume":"16","author":"MP Ducharme","year":"1994","unstructured":"Ducharme MP, Slaughter RL, Edwards DJ. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit. 1994;16(5):513\u20138. https:\/\/doi.org\/10.1097\/00007691-199410000-00013.","journal-title":"Ther Drug Monit"},{"key":"749_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","volume":"83","author":"GD Anderson","year":"2008","unstructured":"Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1\u201310. https:\/\/doi.org\/10.1016\/S0074-7742(08)00001-9.","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"749_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5639\/gabij.2013.0202.025","volume":"2","author":"M Sampson","year":"2013","unstructured":"Sampson M, Cohen-Wolkowiez M, Benjamin D Jr, Capparelli E, Watt K. Pharmacokinetics of antimicrobials in obese children. GaBI J. 2013;2(2):76\u201381. https:\/\/doi.org\/10.5639\/gabij.2013.0202.025.","journal-title":"GaBI J."},{"issue":"3","key":"749_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 2009;48(3):143\u201357. https:\/\/doi.org\/10.2165\/00003088-200948030-00001.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"749_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.cmi.2015.05.002","volume":"21","author":"FB Sime","year":"2015","unstructured":"Sime FB, Roberts MS, Roberts JA. Optimization of dosing regimens and dosing in special populations. Clin Microbiol Infect. 2015;21(10):886\u201393.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"749_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","volume":"50","author":"M Ulldemolins","year":"2011","unstructured":"Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet. 2011;50(2):99\u2013110. https:\/\/doi.org\/10.2165\/11539220-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"749_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jat\/28.3.187","volume":"28","author":"DN Bailey","year":"2004","unstructured":"Bailey DN, Briggs JR. Gentamicin and tobramycin binding to human serum in vitro. J Anal Toxicol. 2004;28(3):187\u20139. https:\/\/doi.org\/10.1093\/jat\/28.3.187.","journal-title":"J Anal Toxicol"},{"issue":"2","key":"749_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/000456328902600207","volume":"26","author":"DP Taggart","year":"1989","unstructured":"Taggart DP, Fraser WD, Fell GS, Wheatley DJ, Shenkin A. Plasma albumin and haemodilution: the problem of interpretation in sequential studies. Ann Clin Biochem. 1989;26(2):132\u20136. https:\/\/doi.org\/10.1177\/000456328902600207.","journal-title":"Ann Clin Biochem"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00749-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-021-00749-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-021-00749-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T02:10:03Z","timestamp":1647051003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-021-00749-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s13318-021-00749-2","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"12 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received to conduct this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"No author has any conflicts of interest in relation to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Jacob Counts, Jessica L. Elefritz, Erica E. Reed and Julia J. Beatty - Protocol development, data collection and manuscript preparation. Marilly Palettas- Statistics and manuscript preparation. Connor Aossey- Data collection and manuscript preparation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Approved by The Ohio State University Wexner Medical Center IRB: October 13, 2020.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent to participate was not obtained, as this was a retrospective study and patients were already discharged or expired.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}